Originally published In Press as doi:10.1074/jbc.M202394200 on April 3, 2002
J. Biol. Chem., Vol. 277, Issue 25, 22710-22717, June 21, 2002
Expression and Localization of Aquaporin Water
Channels in Rat Hepatocytes
EVIDENCE FOR A ROLE IN CANALICULAR BILE SECRETION*
Robert C.
Huebert
,
Patrick L.
Splinter
,
Fabiana
Garcia§,
Raul A.
Marinelli§, and
Nicholas F.
LaRusso
¶
From the
Center for Basic Research in Digestive
Diseases and the ¶ Departments of Internal Medicine and
Biochemistry and Molecular Biology, Mayo Medical School, Clinic and
Foundation, Rochester, Minnesota 55905 and the § Instituto
de Fisiología Experimental, Consejo Nacional de Investigaciones
Científicas y Técnicas, Facultad de Ciencias
Bioquímicas y Farmacéuticas, Universidad Nacional de
Rosario, 2000 Rosario, Santa Fe, Argentina
Received for publication, March 12, 2002, and in revised form, April 3, 2002
 |
ABSTRACT |
Although bile formation requires that large
volumes of water be rapidly transported across liver epithelia,
including hepatocytes, the molecular mechanisms by which water is
secreted into bile are obscure. The aquaporins are a family of 10 channel-forming, integral membrane proteins of ~28 kDa numbered 0-9
that allow water to rapidly traverse epithelial barriers in several
organs including kidney, eye, and brain. We found transcripts of three of 10 aquaporins in hepatocytes (aquaporin 8
aquaporin 9 > aquaporin 0) by reverse transcription-polymerase chain reaction and
quantitative ribonuclease protection assays; immunohistochemistry
confirmed the presence of these three proteins in liver. Immunoblots of subcellular fractions of hepatocytes showed enrichment of aquaporins 0 and 8 in microsomes and canalicular plasma membranes; aquaporin 9 was
enriched only in basolateral plasma membranes. Immunofluorescence of
hepatocyte couplets confirmed the intracellular/canalicular localization of aquaporins 0 and 8 and the basolateral localization of
aquaporin 9. Upon exposure of couplets to a choleretic stimulus (i.e. dibutyryl cAMP), aquaporin 8 redistributed to
the canalicular plasma membrane; the subcellular distributions of
aquaporins 0 and 9 were unaffected. In addition, exposure of couplets
to dibutyryl cAMP caused an increase in canalicular water transport in
the presence and absence of an osmotic gradient, an effect that was blocked by aquaporin inhibitors. These results provide evidence that
aquaporins are present in hepatocytes and that aquaporins are involved
in agonist-stimulated canalicular bile secretion.
 |
INTRODUCTION |
Primary bile is secreted by hepatocytes at the bile canaliculus
and is modified via absorption and secretion of water, ions, and
solutes by cholangiocytes, the epithelial cells that line the
intrahepatic bile ducts. Hepatocytes are polarized epithelial cells
that possess well defined canalicular and basolateral plasma membranes
and are capable of rapidly transporting large volumes of water (1).
Bile consists of 99% water, and water transport by hepatocytes is
thought to occur passively in response to local, transient, osmotic
gradients generated by the active transport of osmotically active
solutes, especially bile acids (2). Two pathways exist by which water
could potentially move from blood to bile across the hepatocyte
epithelial barrier: a paracellular pathway through the tight junctions
between adjacent hepatocytes and a transcellular pathway across
hepatocytes. Furthermore, transcellular water movement across
individual hepatocytes could theoretically occur either by diffusion
through the lipid portion of the sinusoidal and canalicular hepatocyte
plasma membranes or through aquaporin water channels, proteins that
span the plasma membrane and allow for bi-directional, passive flux of
water in response to solute-induced osmotic gradients. The quantitative
contributions of these potential pathways (i.e. paracellular
versus transcellular) and mechanisms (i.e.
diffusion versus channel-mediated) of water transport in hepatocytes are currently unclear.
The aquaporins (AQPs)1 are a
family of integral membrane proteins of ~28 kDa, most of which
function as water-selective channels. To date, 10 AQPs, numbered 0-9,
have been cloned in mammals. These proteins exist in cells as
homotetramers, and water molecules move bidirectionally through the
central pore of each monomer in response to osmotic gradients (3).
Water channels have been shown to be expressed in many epithelial
cells; typically, one or more specific AQP exists in a particular
water-transporting epithelial cell and is either constitutively
expressed or regulated, often by agonist-induced trafficking from an
intracellular vesicular compartment to the plasma membrane allowing for
rapid changes in membrane permeability, depending upon physiological
needs (e.g. AQP2 in response to ADH in the tubule epithelia
of the collecting duct of the kidney) (4-7).
We originally reported that AQP1, AQP2, and AQP4 were not expressed in
hepatocytes and suggested that transmembrane water transport is mainly
via a non-channel-mediated pathway in the basal state (i.e.
in the absence of a choleretic stimulus) (8). Although our more recent
studies, as well as those of others, have shown evidence for the
presence and agonist-induced trafficking of AQP8 in hepatocytes, a
comprehensive study of the expression, subcellular localization, and
trafficking of all of the AQPs in hepatocytes is lacking (9-11).
Furthermore, the functional involvement of AQPs in canalicular water
movement has not been demonstrated. The expression of multiple,
differentially localized and trafficked AQPs in hepatocytes would
support the notion that channel-mediated, transcellular water movement
is an important mechanism for canalicular bile secretion. Thus, the
purpose of the current study was to determine the expression,
subcellular localization, and trafficking of AQPs in hepatocytes and to
assess their role in canalicular bile formation.
 |
EXPERIMENTAL PROCEDURES |
Isolation of Rat Hepatocytes--
Highly purified (>98%)
populations of rat hepatocytes were isolated from the livers of male
Fisher rats, as previously described (12). The livers were perfused
with oxygenated Hepes buffer solution containing 0.02% EGTA
(Sigma) to remove blood cells and then transferred to a
temperature-controlled chamber at 37 °C and perfused with Hepes
buffer solution containing 0.45 mg/ml collagenase D (Roche Molecular
Biochemicals). Following perfusion, the hepatocytes were gently removed
from the biliary tree by mechanical disruption and filtered twice
through 40-µm nylon mesh. The hepatocytes were purified further by
isopycnic centrifugation through a discontinuous Percoll gradient
(Amersham Biosciences) and washed three times in Liebovitz's
L-15 medium (Invitrogen). Viability was greater than 90% as assessed
by trypan blue exclusion. Of the isolated hepatocytes, ~65% were
isolated as single cells, 25% were isolated as couplets, and 10% were
isolated as cell clusters.
RNA Isolation--
Total RNA was extracted from freshly isolated
rat hepatocytes using Tri-Reagent (Sigma). Isolated hepatocytes were
lysed in 1 ml of Tri-Reagent/10 × 106 cells with 5 µl of Glyco-Blue (Ambion Inc., Austin, TX) added as a co-precipitant
and stored at room temperature for 5 min. After addition of 0.1 ml of
1-bromo-3-chloro-propane/1 ml of Tri-Reagent, the samples were
vortexed, incubated for 15 min at room temperature, and centrifuged at
12,000 × g for 15 min at 4 °C. The upper, aqueous phase was collected and transferred to a new tube; to this, 0.5 ml of
isopropanol was added per 1 ml of Tri-Reagent used for the initial
lysis. The samples were stored for 10 min and centrifuged at
12,000 × g for 15 min at 4 °C. After removing the
supernatant, the RNA pellet was washed with 1 ml of 75% ethanol and
repelleted by centrifugation at 12,000 × g for 15 min
at 4 °C. RNA was resuspended in RNA Secure solution (Ambion), and
the concentration and purity were determined by spectrophotometry.
Reverse Transcription-Polymerase Chain Reaction--
5 µg of
total RNA was reverse transcribed using an avian myeloblastosis
virus reverse transcriptase system (Promega, Madison, WI). RNA was
first incubated for 10 min at 70 °C. The reaction mixture included
reverse transcription buffer, 25 mM MgCl2, 10 mM deoxynucleotide triphosphates, avian myeloblastosis
virus reverse transcriptase, RNasin® ribonuclease inhibitor, and
random primers in a final volume of 95 µl. This mixture was added to
the total RNA and incubated for 10 min at room temperature and then
1 h at 42 °C. Heating to 95 °C for 5 min stopped the
reaction. The AQP cDNA was amplified using the polymerase chain
reaction with primers designed toward nonconserved regions of each of
the 10 AQP genes (Table I). The PCR
products were electrophoresed in 1% agarose gels, and the bands were
visualized by ethidium bromide staining. Sequencing was performed on
all positive PCR products (Mayo Molecular Core Facility, Rochester, MN)
to confirm the identity of the amplified genes.
Quantitative Ribonuclease Protection Assay (Q-RPA)--
AQP
mRNA expression was confirmed and quantified using quantitative
ribonuclease protection assays, as previously described (13). All
positive PCR reactions were gel purified using a gel extraction kit
(QIAquick; Qiagen, Inc., Valencia, CA) and cloned into the pCR II dual
promoter vector (Invitrogen Corp., San Diego, CA). The
32P-labeled antisense probes were prepared by transcribing
with the SP6 polymerase and labeling with [
-32P]UTP.
The sense products were transcribed with T7 polymerase and then diluted
to 0.1, 0.2, 0.5, and 1.0 ng for the preparation of the standard curve.
The RPAs were performed by using 40 µg of total RNA from pure
populations of isolated hepatocytes. The RPA probe was purified by
excision from a 5% acrylamide, 8 M urea denaturing gel and
elution into 0.5 M ammonium acetate, 1 mM EDTA, 0.1% SDS at 37 °C. The antisense probe was hybridized with
RNA for the standard curve or with total hepatocyte RNA for 12 h
at 45 °C. The unhybridized RNA was digested using a mixture of RNase A and RNase T. The protected hybrid was electrophoresed in a 5% acrylamide, 8 M urea gel and detected by exposure to Biomax
MS x-ray film (Eastman Kodak, Rochester, NY). Densitometric analysis was performed for each probe to create a standard curve using the
in vitro transcribed sense strands as template.
Preparation of Mixed Plasma Membranes--
Mixed plasma
membranes were prepared from total rat liver using the method of
Cefaratti et al. (14) with modifications or from isolated
hepatocytes, as previously described (11). Briefly, the livers were
perfused with oxygenated Hepes buffer solution containing 1 mM EGTA and then minced and homogenized in 50 ml of
isolation medium (250 mM sucrose, 50 mM Tris,
pH 8.0) by 10 passes with a loose fitting (type A) Dounce homogenizer
followed by three passes with a tight fitting (type B) Dounce
homogenizer. The homogenate was diluted to 6% (w/v) in the same buffer
and centrifuged at 1400 × g for 10 min. The pellets were
resuspended again at 6% in isolation medium. 1.4 ml of Percoll
(Amersham Biosciences) was added for every 10.4 ml of resuspension.
After centrifugation at 34,500 × g for 30 min, the
top, fluffy layer containing the mixed plasma membrane was removed,
washed in incubation medium (250 mM sucrose, 50 mM Tris, pH 8.0), and resuspended in phosphate-buffered saline. In some experiments, isolated hepatocytes were preincubated with 100 µM d-cAMP and 100 µM IBMX at
37 °C for 10 min prior to membrane isolation. The aliquots of mixed
plasma membrane from the total rat liver (but not from isolated
hepatocytes) were used for subsequent preparation of canalicular and
basolateral plasma membranes.
Preparation of Canalicular and Basolateral Plasma
Membranes--
Canalicular and basolateral plasma membrane fractions
were isolated from aliquots of total rat liver mixed plasma membrane using the method of Cefaratti et al. (14) with
modifications. Mixed plasma membranes were washed with five volumes of
washing buffer (250 mM sucrose, 25 mM K-Hepes,
pH 7.4) and centrifuged at 34,500 × g for 30 min. The
pellet was resuspended to a concentration of 5 mg protein/ml,
homogenized by 75 passes with a tight fitting (type B) Dounce
homogenizer, and layered onto a discontinuous sucrose gradient (2.6 ml
each of 43%, 46%, and 52% sucrose). After centrifugation at
93,000 × g for 1 h, the pellet (basolateral plasma membrane) and the bands at the top of the 43% layer and at the
43%/46% interface (canalicular plasma membrane) were collected. The
bands were diluted with five volumes of washing buffer and spun at
35,000 × g for 30 min.
Preparation of Microsomal Membranes--
A microsomal fraction
consisting of intracellular vesicles was isolated from total rat liver,
as previously described (15). Liver homogenate was centrifuged at
200,000 × g for 60 min on a discontinuous 1.3 M sucrose gradient. The plasma membrane band and pellet
were removed. The 1.3 M sucrose gradient was sonicated, diluted to 0.3 mol/liter, and centrifuged at 17,000 × g for 30 min. The resulting supernatant was centrifuged at
200,000 × g for 60 min to yield the microsomal
membrane fraction.
Confirmation of Canalicular and Basolateral Membrane
Purity--
The purity of the canalicular and basolateral membrane
subfractions was confirmed using a combination of enzymatic assays and
Western blots for specific canalicular and basolateral protein markers
(Table II). Alkaline phosphatase (a
canalicular marker) activity was assessed using a commercially
available enzyme assay kit (Sigma).
Na+/K+ ATPase (a basolateral marker)
activity was assessed using the method of Scharschmidt et
al. (16). Immunoblots were performed for aminopeptidase N (a
canalicular marker) and the Na+/taurocholate
co-transporting protein (a basolateral marker) (17, 18). Enzymatic
assays for alkaline phosphatase (n = 3) showed a
7.5-fold enrichment in canalicular versus basolateral plasma membrane. Assays for the Na+/K+ ATPase
(n = 3) showed a 12.5-fold enrichment in basolateral
versus canalicular plasma membranes. Western blots for
aminopeptidase N (15 µg of protein/lane) and
Na+/taurocholate co-transporting protein (25 µg of
protein/lane) showed canalicular and basolateral localization,
respectively, as expected.
Immunoblotting--
MPM, CPM, BPM, and microsomal membranes from
total rat liver or MPM from isolated rat hepatocytes were heated to
60 °C for 10 min in sample buffer containing 0.8 M
dithiothreitol (Sigma) and 10% SDS (Fisher) for protein denaturation
and solubilization. The samples were then subjected to electrophoresis
through 7.5% or 12% SDS-polyacrylamide gels and transferred overnight
to nitrocellulose sheets. The blots were blocked with 5% (w/v) nonfat
dry milk and 0.2% (v/v) Tween 20. After blocking, the blots were
incubated with affinity-purified rabbit anti-rat antibodies to the
various AQPs (Alpha Diagnostic International, San Antonio, TX) at a
dilution of 1:2000 to 1:5000 for 1 h at room temperature or
overnight at 4 °C. Goat anti-aminopeptidase N (Santa Cruz
Biotechnology, Santa Cruz, CA) was used at a dilution of 1:100. Rabbit
anti-Na+/taurocholate co-transporting protein fusion
protein (kindly provided by Dr. Peter Meier) was used at a dilution of
1:500. The blots were washed and incubated for 1 h at room
temperature with a horseradish peroxidase-conjugated goat anti-rabbit
immunoglobulin (Tago, Inc., Burlingame, CA) or horseradish
peroxidase-conjugated donkey anti-goat immunoglobulin (Santa Cruz
Biotechnology). Protein bands were detected using an enhanced
chemiluminescence detection system (ECL Plus; Amersham Biosciences).
After exposing the nitrocellulose sheets to Kodak XAR film, the
autoradiographs were scanned and quantified by densitometry using
Molecular Analyst software (Bio-Rad).
Immunohistochemistry--
Whole liver was perfused with Hepes
buffer solution, pH 7.4, containing 0.02% EGTA and then harvested,
sliced, and fixed by immersion with 4% paraformaldehyde. The tissue
was embedded in paraffin or Optimal Cutting Temperature
embedding medium. Paraffin and frozen sections were cut to a thickness
of 4-8 µm. The sections were placed in 10 mM citrate
buffer (pH 6.0) and microwaved to improve staining by antigen
unmasking. After washing and quenching of endogenous peroxidase, the
sections were blocked and incubated with rabbit affinity-purified
antibodies against the various rat AQPs (2-10 µg/ml; Alpha
Diagnostics International) overnight at 4 °C. The remaining steps
were carried out using an immunoperoxidase detection procedure
(Vectastain Elite ABC Kit; Vector Laboratories, Burlingame, CA). The
peroxidase was visualized by reaction with diaminobenzidine and
hydrogen peroxide (diaminobenzidine peroxidase substrate kit; Vector
Laboratories) and counterstaining with hematoxylin.
Immunofluorescence--
Collagen-coated coverslips were seeded
with freshly isolated hepatocytes containing ~100,000 couplets and
incubated for 4 h at 37 °C in Liebovitz's L-15 medium
(Invitrogen) to re-establish cell polarity. After washing with medium,
the cells were fixed with 2% paraformaldehyde and 0.01%
glutaraldehyde for 10 min at 37 °C. Fixative was removed with six
1-min washes in PBS. The cells were then permeablized for 5 min in
0.2% Triton. The cells were again washed with six 1-min washes in PBS
and then blocked with 5% goat serum and 5% glycerol for 1 h at
room temperature. The cells were incubated with rabbit
affinity-purified antibodies against the various rat AQPs (1:500
dilution; Alpha Diagnostic International) for 1 h at room
temperature. After three 10-min washes in PBS, the cells were incubated
with a Texas Red-conjugated goat anti-rabbit secondary antibody
(Molecular Probes, Eugene, OR). The coverslips were again washed three
times for 10 min in PBS followed by one 10-min wash in deionized water
and then mounted using Prolong® Antifade mounting medium
(Molecular Probes). The cells were examined using scanning laser
confocal microscopy. Fluorescence intensity was quantified and
displayed graphically using LSM 510 Image Examiner software (Carl
Zeiss, Thornwood, NY). In some experiments, the couplets were
preincubated with 100 µM d-cAMP and 100 µM
IBMX at 37 °C for 10 min prior to fixation.
Osmotic Water Transport Studies--
35-mm glass-bottomed
culture dishes (MatTek, Ashland, MA) were coated with type I collagen
from calf skin (Sigma) and seeded with ~100,000 freshly isolated
hepatocyte couplets. The couplets were cultured for 6 h in
Liebovitz's L-15 medium. The couplets were then exposed to hypertonic
(350 mosmol) Krebs-Ringers buffer to shrink the canalicular
space to ~40% of its original size. Then the hypertonic
Krebs-Ringers buffer was removed and replaced with hypotonic (200 mosmol) Krebs-Ringers buffer to stimulate secretion into and
re-expansion of the canalicular space. The canalicular changes were
recorded using time lapse microscopy with differential interference
contrast optics. Major (a) and minor (b)
axes of the canaliculi were measured every 20 s for a total of 10 min. Canalicular volume was calculated assuming an ellipsoid shape of
the lumen according to the following equation.
|
(Eq. 1)
|
In some experiments, the couplets were preincubated with 100 µM d-cAMP and 100 µM IBMX (Sigma) at
37 °C for 10 min and/or with 500 mM
Me2SO (Sigma) or 500 µM phloretin
(Sigma), two AQP inhibitors that did not affect hepatocyte viability as
determined by trypan blue staining (data not shown) (11, 19-22).
d-cAMP-induced Secretion Experiments--
35-mm glass-bottomed
culture dishes (MatTek) were coated with type I collagen from calf skin
(Sigma) and seeded with ~100,000 freshly isolated hepatocyte
couplets. The couplets were cultured for 6 h in Liebovitz's L-15
medium. The couplets were incubated for 60 min with 100 µM d-cAMP and 100 µM IBMX (Sigma) and/or
with 500 mM Me2SO (Sigma) or 500 µM phloretin (Sigma). The canalicular volume changes over
60 min were measured using differential interference contrast
microscopy, as above. Because focal drift becomes a significant problem
during this time frame, 4-µm beads were added to each culture dish as
a focal reference. In addition, hepatocyte cellular volume was assessed
by measuring the cellular diameter and calculating cellular volume
according to the following equation.
|
(Eq. 2)
|
Protein Assay--
Protein concentrations were determined using
the fluorescamine method with bovine serum albumin as a standard.
 |
RESULTS |
AQP Expression by RT-PCR--
RT-PCR was run for each of the 10 AQPs on total RNA derived from pure populations of isolated rat
hepatocytes (Fig. 1). Fig. 1 shows 1%
agarose gels of the PCR products with ethidium bromide staining for
AQP0, AQP8, and AQP9. The PCR products were sequenced, and the
identities of the amplicons were verified by data base homology
searches (BLAST; NCBI, National Institutes of Health). When using
primers for AQPs 1, 2, 4, 5, 6, and 7, no amplification products were
observed. These data are consistent with data previously published from
our laboratory showing that AQP1, AQP2, and AQP4 are not expressed in
hepatocytes. A positive band was also seen for AQP3 (data not shown),
but AQP3 was shown to be negative by Q-RPA. This band for AQP3 may
represent extremely low levels of AQP3 expression in hepatocytes (below
the detection limits of the RPA) or a false positive because of small
amounts of contaminating mRNA from endothelial or blood cells. The
extreme sensitivity of RT-PCR leaves it vulnerable to false positives
resulting from small numbers of contaminating cells carried over during
hepatocyte isolation. Thus, this method was used only as an initial
screening technique to rule out those AQPs that are not expressed in
hepatocytes. Each AQP cDNA was amplified in a separate PCR reaction
alongside appropriate positive and negative controls.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 1.
RT-PCR showing expression of AQPs in
hepatocytes. Total RNA from rat hepatocytes was reverse
transcribed using random primers and then PCR-amplified with primers
designed to amplify a nonconserved region of each AQP cDNA.
Positive bands are shown for AQP0, AQP8, and AQP9.
|
|
Quantitation of AQP mRNAs by Q-RPA--
Q-RPAs were used to
confirm and quantify the mRNAs in pg of AQP mRNA/µg of total
RNA (Table III). The data are expressed
as the means ± S.E. of three separate experiments. The presence
of three AQP mRNAs (AQP0, AQP8, and AQP9) was confirmed and
quantified by Q-RPA. The AQP8 message was expressed at the highest
level followed by AQP9 > AQP0. The relative abundance of the
three mRNA transcripts suggests that the three AQP homologues exist
in varying amounts. However, caution is necessary when extrapolating
conclusions about protein abundance from nucleic acid data because of
varying rates of mRNA degradation. AQP3 was not detected by Q-RPA
(data not shown). Each AQP mRNA was labeled in a separate RPA
alongside appropriate positive and negative controls (data not
shown).
View this table:
[in this window]
[in a new window]
|
Table III
Quantitative ribonuclease protection assay for AQP mRNA in
hepatocytes
The values are the means ± S.E. of the AQP mRNA levels
interpolated from a standard curve generated by a serial dilution of
cRNAs; n = 3 for each AQP. The data are expressed as pg
of AQP mRNA/µg of total RNA.
|
|
Immunohistochemistry--
Immunohistochemical staining of whole
liver sections was used to confirm the presence of the AQP proteins
(Fig. 2). Hepatocytes were positively
stained for AQP0, AQP8, and AQP9. AQP0 (Fig. 2, A and
D) showed strong intracellular staining, mainly in
pericentral hepatocytes; any canalicular staining was most likely
obscured by the strong intracellular signal. AQP8 (Fig. 2, B
and E) showed a punctate, intracellular staining pattern and
some staining at the canaliculi with increased intensity in the
pericentral hepatocytes. AQP9 (Fig. 2, C and F)
showed very strong staining on the basolateral surfaces of all
hepatocytes. These data confirm the presence of AQP0, AQP8, and AQP9 in
hepatocytes and suggest differential subcellular localization of the
three proteins as well as differences in their lobular distribution.
Controls using nonimmune IgG (Vector Laboratories) or omission of
primary or secondary antibody revealed no labeling (data not
shown).

View larger version (113K):
[in this window]
[in a new window]
|
Fig. 2.
Immunohistochemistry in whole liver
sections. 4-8-µm sections were stained via a
diaminobenzidine/peroxidase reaction, counterstained with hematoxylin,
and visualized by light microscopy at magnifications of 4×
(A-C) and 60× (D-F). A and
D, staining for AQP0 was mainly intracellular and was most
intense in hepatocytes surrounding the central vein. B and
E, staining for AQP8 was mainly intracellular and was also
most intense in pericentral hepatocytes. C and F,
staining for AQP9 was strong at the basolateral membrane surfaces of
all hepatocytes.
|
|
Immunoblotting for AQPs--
Immunoblots for AQP0, AQP8, and AQP9
in the basal state were run on subcellular fractions of hepatocytes
enriched in MPM, CPM, BPM, or intracellular vesicles (i.e.
microsomal membranes) (Fig. 3). The data
are expressed as the means densitometric values ± S.E. of three
separate experiments with a representative immunoblot pictured below.
AQP0 and AQP9 showed bands near 28 kDa, as expected. AQP8 showed a band
at 34 kDa, consistent with its known glycosylation (11). Immunoblots
for AQP0 (Fig. 3A) showed enrichment in microsomes versus MPM and in CPM versus BPM, respectively.
Similarly, immunoblots for AQP8 (Fig. 3B) showed enrichment
in both microsomes and in CPM. Immunoblots for AQP9 (Fig.
3C) showed enrichment in MPM versus microsomes
and in BPM versus CPM, respectively. These results are
consistent with our immunohistochemical data.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 3.
Immunoblots for AQP0, AQP8, and AQP9 in the
basal state. MPM, CPM, BPM, and microsomes from total rat liver
were loaded onto 12% SDS-polyacrylamide gels using 25 µg of total
protein/lane as starting material. Immunoblots were
performed using affinity-purified rabbit anti-AQP primary antibodies
and goat anti-rabbit secondary antibodies, visualized via
chemiluminescence, and quantified using densitometry. The data are
expressed in arbitrary densitometry units (n = 3;
means ± S.E.) with representative immunoblots pictured below.
A, blots for AQP0 showed enrichment in microsomes
versus MPM and in CPM versus BPM. *,
p < 0.05 versus MPM; #, p < 0.05 versus BPM. B, blots for AQP8 also AQP0
showed enrichment in microsomes versus MPM and in CPM
versus BPM. *, p < 0.05 versus
MPM; #, p < 0.05 versus BPM. C,
blots for AQP9 showed enrichment in MPM versus microsomes
and in BPM versus CPM. % p < 0.05 versus microsomes; +, p < 0.05 versus CPM.
|
|
Immunofluorescence--
Immunofluorescent staining of isolated
hepatocyte couplets and subsequent quantitative analysis further
confirmed the subcellular localization of AQP0, AQP8, and AQP9 in
hepatocytes as well as demonstrating a d-cAMP-stimulated redistribution
of AQP8 (Fig. 4). It has been shown that
hepatocyte couplets redevelop their polarity upon isolation and short
term culture (23). The interface area between the two coupled cells
contains proteins derived from canaliculi, whereas the outer perimeter
of the couplets contains proteins derived from basolateral surfaces.
Representative couplets are displayed as raw confocal images,
three-dimensional fluorescence intensity plots, and fluorescence
profile graphs. In the basal state, AQP0 (Fig. 4A) and AQP8
(Fig. 4B) show strong staining in intracellular vesicles and
some staining at the canaliculus. AQP8 staining was clearly
redistributed from the interior of the cell to the CPM upon stimulation
with d-cAMP (Fig. 4E), whereas AQP0 localization was
unaffected (Fig. 4D). AQP9 stained mainly the BPM in both
the basal (Fig. 4C) and d-cAMP-stimulated (Fig. 4F) states, suggesting that this AQP is constitutively
expressed on the basolateral plasma membrane and is not trafficked in
response to d-cAMP. These experiments provide further evidence of the
intracellular and canalicular localization of AQP0 and AQP8 and the
constitutively basolateral localization of AQP9 in the basal state. In
addition, the data show that AQP8 (but not AQP0 or AQP9) can be
redistributed to the canalicular plasma membrane by the choleretic
agonist, d-cAMP. Controls using nonimmune IgG (Vector Laboratories) or omission of primary or secondary antibody revealed no specific (punctate) labeling, but a small amount of autofluorescence was evident
when using the same confocal settings as the AQP experiments (data not
shown).

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 4.
Immunofluorescence in isolated hepatocyte
couplets. The couplets were fixed and stained with
affinity-purified rabbit anti-AQP primary antibodies and Texas
Red-conjugated goat anti-rabbit secondary antibodies. The couplets were
then visualized by laser scanning confocal microscopy, and the
fluorescence was quantified using Zeiss 510 Image Examiner software.
The results are displayed as raw confocal images, fluorescence profile
graphs, and three-dimensional fluorescence intensity plots.
A, staining for AQP0 in the basal state was observed within
the cells and at the canaliculus. B, staining for AQP8 in
the basal state was observed primarily within the cells but also at the
canaliculus. C, staining for AQP9 was localized mainly at
the BPM in the basal state. D, AQP0 staining was unaffected
by treatment with d-cAMP. E, AQP8 staining redistributed
from an intracellular vesicular compartment to the CPM upon treatment
with d-cAMP. F, AQP9 staining remained strong at the BPM
after d-cAMP treatment.
|
|
Immunoblotting with or without d-cAMP--
Immunoblotting of
plasma membrane fractions of isolated rat hepatocytes treated with or
without d-cAMP confirmed that AQP8 (but not AQP0 or AQP9) is trafficked
to the plasma membrane in response to a choleretic stimulus (Fig.
5). Immunoblots for AQP0 and AQP9 (Fig.
5, A and C) show no change after treatment with d-cAMP, whereas there is a 4-fold increase in plasma membrane AQP8
(Fig. 5B). These data further support the concept that AQP8 undergoes regulated exocytic insertion into the canalicular plasma membrane upon stimulation with a choleretic agonist.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 5.
Immunoblots with or without d-cAMP. MPM
from isolated hepatocytes treated with or without 100 µM
d-cAMP were loaded onto 12% SDS-polyacrylamide gels using 20 µg of
total protein/lane as starting material. Immunoblots were
performed using affinity-purified rabbit anti-AQP primary antibodies
and goat anti-rabbit secondary antibodies, visualized via
chemiluminescence, and quantified using densitometry. The data are
expressed in arbitrary densitometry units (n = 3;
mean ± S.E.) with representative immunoblots pictured below.
A, blots for AQP0 show no significant change after d-cAMP
treatment. B, blots for AQP8 show a significant increase
after d-cAMP treatment. *, p < 0.05 versus
control. C, blots for AQP9 showed no significant change
after d-cAMP treatment.
|
|
Osmotic Water Transport Studies--
Functional studies in
isolated hepatocyte couplets were used to assess the importance of
AQPs in osmotic water movement across hepatocytes (Fig.
6). Osmotic water transport in the basal
state was unaffected by the AQP inhibitors, Me2SO or
phloretin (Fig. 6A). After initial shrinkage of the
canalicular space to ~40% of original size, control cells showed a
recovery of canalicular volume (to ~65% of original size) during 10 min of hypoosmotic stress. This recovery was unaffected by AQP
inhibitors, suggesting that hepatocyte water movement is not
channel-mediated in the basal or unstimulated state, consistent with
previous studies from our laboratory (8). After incubation with d-cAMP,
the rate of canalicular water transport increased during 10 min of hypoosmotic stress, resulting in a larger total increase in canalicular volume (to ~120% of original size). This effect was completely abolished when the couplets were also exposed to Me2SO or
phloretin (Fig. 6B), suggesting that the d-cAMP-induced
increase in osmotic water movement into the canaliculus is
AQP-dependent.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 6.
Osmotic water transport studies. Freshly
isolated hepatocyte couplets were cultured for 6 h and then
pretreated with or without 100 µM d-cAMP and 100 µM IBMX in the presence and absence of Me2SO
or phloretin. After initial shrinkage of the canalicular space using a
hypertonic buffer solution, secretion was stimulated by exposing the
cells to a hypotonic stress. The images were obtained during a period
of 10 min using time lapse differential interference contrast imaging,
and then canalicular volume was calculated assuming an ellipsoid shape
of the lumen. The data are expressed in relative canalicular volume as
percentages of initial versus time. A, in the
basal state, treatment of the couplets with the AQP inhibitors
Me2SO or phloretin did not significantly affect osmotic
water transport into the canaliculus (n = 4-6;
mean ± S.E.). B, treatment with d-cAMP significantly
increased osmotic water transport into the canaliculus, an effect that
could be completely abrogated by inhibitors of AQP water channels
(n = 4-6; mean ± S.E.). *, p < 0.05.
|
|
d-cAMP-induced Secretion--
d-cAMP-induced secretion in isolated
hepatocyte couplets in the absence of an external osmotic gradient was
also shown to be AQP-dependent (Fig.
7). The driving force for this secretion is of physiological size and is generated by the action of the choleretic agonist, d-cAMP. Fig. 7 shows the mean ± S.E. of four to six separate experiments for each treatment group. A representative couplet after 60 min of treatment is also shown for each group. Canalicular volume in control cells increased only slightly during 60 min (< 20%). In contrast, couplets treated with d-cAMP showed canalicular volume increases of ~300% during the 60-min experiment. This secretory effect was reduced to control levels when cells were also treated with the AQP inhibitors, Me2SO or
phloretin. Treatment with Me2SO alone or phloretin alone
had no significant effect on canalicular volume for 60 min (data not
shown). These results suggest an AQP dependence of the d-cAMP-induced
increase in canalicular secretion in a physiologically relevant model
system. Hepatocyte cellular volume was unaffected by all the
experimental perturbations (d-cAMP, Me2SO, and phloretin,
alone or in combination; data not shown).

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 7.
d-cAMP-induced bile secretion. Freshly
isolated hepatocyte couplets were cultured for 6 h and then
pretreated with and without 100 µM d-cAMP and 100 µM IBMX in the presence and absence of Me2SO
or phloretin. Secretion into the canalicular space was recorded for a
period of 60 min using differential interference contrast imaging, and
then canalicular volume was calculated assuming an ellipsoid shape of
the lumen. 4-µm beads were added to each culture dish as a focal
reference. The data are expressed in relative canalicular volume as
percentages of initial with a representative couplet from each
treatment group after 60 min pictured above. d-cAMP caused a
significant increase in canalicular secretion, and this effect could be
completely abrogated by both Me2SO and phloretin. *,
p < 0.05.
|
|
 |
DISCUSSION |
The major findings reported here relate to the expression and
subcellular localization of aquaporin water channels in rat hepatocytes
and their possible role in canalicular bile secretion. Using molecular,
biochemical, and morphological approaches in both highly purified rat
hepatocytes and whole rat liver, we showed that: (i) the message and
protein of three (AQP0, AQP8, and AQP9) of the 10 known AQPs are
expressed in hepatocytes in variable amounts (AQP8
AQP9 > AQP0); (ii) AQP9 is found principally on the basolateral hepatocyte
membrane, whereas AQP0 and AQP8 are principally localized
intracellularly and to a lesser degree on the canalicular plasma
membrane; (iii) AQP0 and AQP8 are expressed to a larger degree in
hepatocytes surrounding the central vein, whereas AQP9 is uniformly
distributed within the hepatic lobule; (iv) the amount of AQP8 in the
canalicular plasma membrane markedly increases after exposure of
hepatocytes to a choleretic agonist; and (v) two inhibitors of AQPs
block agonist-induced (but not basal) canalicular secretion in isolated
hepatocyte couplets. Our results are consistent with the notion that
AQPs play a role in agonist-induced canalicular bile secretion by hepatocytes.
AQPs have a wide range of tissue distribution in mammals, but their
expression is most notably associated with tissues involved in the
rapid transport of large volumes of water such as kidney, eye, brain,
secretory glands, and more recently, colon (4-7, 9). Some epithelial
cells express more than one AQP with the different AQP homologues
existing at different subcellular locations. Also, some AQPs undergo
agonist-induced exocytic insertion and endocytic retrieval into and out
of the plasma membrane as a mechanism for regulating AQP-mediated water
transport. For example, the principle cells of the collecting duct in
the kidney contain AQP2 in intracellular vesicles and AQP3 and AQP4 on
their basolateral plasma membrane in the basal state; after exposure to
vasopressin, the amount of AQP2 (but not AQP3 or AQP4) in the apical
plasma membrane is increased via insertional exocytosis promoting
reabsorption of water within this segment of the nephron (6). After
withdrawal of vasopressin, AQP2 molecules are removed from the apical
plasma membrane by endocytosis. Similarly, the cells of the salivary and lacrimal glands contain AQP5 at the apical domain and AQP3 or AQP4
at the basolateral domain (4, 5). AQP5 in the salivary gland, which is
normally sequestered in intracellular vesicles, redistributes to the
apical plasma membrane upon stimulation by the neurotransmitter,
epinephrine (24). Finally, we have demonstrated that AQP4 is
constitutively expressed on the basolateral membrane of cholangiocytes,
whereas AQP1, normally residing in intracellular vesicles, undergoes
secretin-induced exocytic insertion into the apical cholangiocyte
membrane (15, 25, 26). Thus, a generalizable model accounting for the
physiological role of AQPs in water-transporting epithelia is
developing in which multiple, differentially localized, constitutively
expressed or trafficked AQPs function together to facilitate regulated
transcellular water movement in water-transporting epithelia in both
the basal and stimulated states.
d-cAMP has been shown to stimulate canalicular bile secretion in the
perfused rat liver (27) as well as in isolated rat hepatocyte couplets
(28). Moreover, recent evidence suggests that cAMP stimulates the
canalicular targeting of vesicles containing the
Cl
/HCO
(29), the bile
salt export pump (28), and the organic anion transporter, Mrp2 (30,
31), processes that may underlie the choleretic effect of cAMP. In this
study, we showed that d-cAMP stimulated the insertion of AQP8-containing vesicles into the canalicular membrane of hepatocytes. We propose that this process facilitates the movement of water coupled
to the secretion of osmotically active solutes and, in turn, the
elaboration of canalicular bile.
We found that AQP0 was present in hepatocytes and was localized
principally to intracellular vesicles and that, unlike AQP8, this
localization was unaffected by d-cAMP. This protein had previously been
thought to be expressed exclusively in the lens fiber cells of the eye
where it functions as a water channel of low permeability but also as a
structural protein important in cell-cell adhesion (32). The
significance of AQP0 expression in hepatocytes is currently unclear,
but we speculate that its role may be unrelated to canalicular bile secretion.
Recently, we showed that AQP8 is localized largely to intracellular
vesicles within isolated hepatocytes in the unstimulated state and was
redistributed to the hepatocyte plasma membrane via stimulation with
d-cAMP (11). Our results here extend these findings by demonstrating
that the canalicular membrane is the specific domain of the plasma
membrane into which the insertion of AQP8 occurs. This mechanism of
regulation may allow hepatocytes to quickly and selectively increase
the osmotic permeability of their canalicular plasma membrane in
response to a choleretic stimulus. AQP8 expression has also been
demonstrated on the luminal side of seminiferous tubules, the apical
membrane of pancreatic acinar cells, and in both absorptive epithelia
of the colon and acinar cells of the salivary gland; whether AQP8 in
these tissues is also regulated by a trafficking mechanism has not been
explored (10, 33-36).
Others recently suggested that AQP9 resides principally on the
sinusoidal (basolateral) plasma membranes of hepatocytes (9). Our
results support this topography using multiple experimental techniques,
but also show that AQP9 localization does not change in response to a
choleretic stimulus. This constitutively basolateral localization of
AQP9 is thought to facilitate trans-basolateral water
movement, a critical component of transcellular movement of water
across hepatocytes. Other studies have shown AQP9 to be expressed in
epididymus, testis, spleen, and brain, but the subcellular location of
AQP9 in these cell types is unclear.
Historically, water transport in hepatocytes has been assumed by many
to occur via a paracellular pathway (i.e. between cells). This assumption was based on evidence involving tight junction penetration of nonaqueous substances and on in vitro
electrical resistance measurements suggesting that hepatocytes are
"leaky epithelia" (37-39). More recently, we suggested that
transcellular water movement might account for the high osmotic
permeability coefficient of isolated hepatocytes (i.e.
Pf = 66.4 × µm/s) we previously observed
from careful measurements. This value is actually higher, for example,
than that of cholangiocytes (i.e. Pf = 50.0 × µm/s), which we have shown to transport water via a
transcellular, channel-mediated pathway (20, 40). We previously
proposed that the transcellular mechanism by which hepatocytes
transported water was mainly via a non-channel-mediated pathway
(i.e. via the lipid phase) in the basal state (8). This
conclusion was based on careful measurements demonstrating a
temperature dependence of hepatocyte membrane permeability and on an
apparent lack of water channel expression. The calculated activation
energy (Ea) from these experiments was 12.8 kcal/mol (outside of the typical range for channel-mediated transport)
and was decreased to 3.6 kcal/mol in the presence of amphotericin B, a
substance that forms artificial water channels in plasma membranes. Our
functional studies here using AQP inhibitors also support the concept
that transcellular water transport by hepatocytes in the basal state occurs mainly via a non-channel-mediated pathway. Our discovery of the
expression of three water channels with distinct subcellular locations
within hepatocytes and our data demonstrating that the insertion of
AQP8 into the canalicular plasma membrane can be stimulated by a
choleretic agonist suggest that water transport across the hepatocyte
epithelial barrier in response to a choleretic stimulus (as opposed to
the basal, unstimulated state) is due to a transcellular pathway
facilitated by the regulated and constitutive expression of AQP8 and
AQP9, respectively. The role of AQP0, which appears to be localized
primarily in intracellular vesicles, remains obscure. Indeed, we have
now demonstrated that in addition to the diffusional and paracellular
routes, a regulated, channel-mediated component for water transport by
hepatocytes also exists (Fig. 8). The
quantitative contributions of these various pathways to total
canalicular bile secretion is under active investigation.

View larger version (85K):
[in this window]
[in a new window]
|
Fig. 8.
Proposed model for water transport during
canalicular bile secretion. AQP0 and AQP8 are localized in
intracellular vesicles and on the canalicular plasma membrane, whereas
AQP9 is localized on the basolateral plasma membrane. AQP8 is inserted
into the canalicular plasma membrane in response to d-cAMP, but the
localization of AQP0 and AQP9 is unaffected by d-cAMP. The regulated
insertion of AQP8-containing vesicles into the secretory pole
(i.e. canalicular membrane) of hepatocytes would facilitate
the movement of water coupled to the secretion of osmotically active
solutes and, in turn, the elaboration of canalicular bile.
|
|
In summary, our findings show that hepatocytes express multiple
differentially localized and differentially trafficked AQPs, a pattern
increasingly being recognized in water transporting epithelial cells.
Although hepatocyte water movement appears to be non-channel-mediated
in the basal state, d-cAMP-induced water secretion can be abrogated by
inhibitors of AQPs. The data suggest that water channels play an
important role in the transcellular transport of water during primary
bile secretion by the hepatocyte. Further studies will be necessary to
determine the quantitative contribution of channel-mediated water
movement relative to diffusion across and movement between hepatocytes,
as well as the exact role and mechanism of regulation for each AQP homologue.
 |
ACKNOWLEDGEMENTS |
We acknowledge Deb Hintz for secretarial
support, Dr. Bing Huang for assistance with confocal microscopy, and
Pamela Tietz, Dr. Anatoly Masyuk, and Dr. Giuseppe Calamita for
valuable discussions.
 |
FOOTNOTES |
*
This work was supported by Grant DK24031 from the National
Institutes of Health (to N. F. L.), by funds from the Mayo
Foundation, by Grant PICT 03589 from Agencia Nacional de
Promoción Científica y Tecnológica (R. A. M.), and by a Grant from Subsecretaría de Investigación y
Tecnología, Ministerio de Salud.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Center for Basic
Research in Digestive Diseases, Mayo Medical School, Clinic and Foundation, 200 First St. SW, Rochester, MN 55905. Tel.:
507-284-1006; Fax: 507-284-0762; E-mail:
larusso.nicholas@mayo.edu.
Published, JBC Papers in Press, April 3, 2002, DOI 10.1074/jbc.M202394200
 |
ABBREVIATIONS |
The abbreviations used are:
AQP, aquaporin;
d-cAMP, dibutyryl cAMP;
IBMX, isobutyl methyl xanthine;
RT, reverse
transcription;
Q-RPA, quantitative ribonuclease protection assay;
PBS, phosphate-buffered saline;
MPM, mixed plasma membrane;
CPM, canalicular
plasma membrane;
BPM, basolateral plasma membrane.
 |
REFERENCES |
| 1.
|
Meier, P. J.
(1988)
Semin. Liver Dis.
8,
293-307[Medline]
[Order article via Infotrieve]
|
| 2.
|
Meier, P. J.,
and Stieger, B.
(2000)
News Physiol. Sci.
15,
89-93[Abstract/Free Full Text]
|
| 3.
|
Walz, T.,
Hirai, T.,
Murata, K.,
Heymann, J. B.,
Mitsuoka, K.,
Fujiyoshi, Y.,
Smith, B. L.,
Agre, P.,
and Engel, A.
(1997)
Nature
387,
624-627[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Borgnia, M.,
Nielsen, S.,
Engel, A.,
and Agre, P.
(1999)
Annu. Rev. Biochem.
68,
425-458[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
King, L.,
Yasui, M.,
and Agre, P.
(2000)
Mol. Med. Today
6,
60-65[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Verkman, A.
(1999)
J. Am. Soc. Nephrol.
10,
1126-1135[Abstract/Free Full Text]
|
| 7.
|
Masyuk, A. I.,
Marinelli, R. A.,
and LaRusso, N. F.
(2002)
Gastroenterology
122,
545-562[Medline]
[Order article via Infotrieve]
|
| 8.
|
Yano, M.,
Marinelli, R.,
Roberts, S.,
Balan, V.,
Pham, L.,
Tarara, J.,
deGroen, P.,
and LaRusso, N. F.
(1996)
J. Biol. Chem.
271,
6702-6707[Abstract/Free Full Text]
|
| 9.
|
Elkjaer, M.,
Vajda, Z.,
Nejsum, L.,
Kwon, T.,
Jensen, U.,
Amiry-Moghaddam, M.,
Frokiaer, J.,
and Nielsen, S.
(2000)
Biochem. Biophys. Res. Commun.
276,
1118-1128[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Elkjaer, M. L.,
Nejsum, L. N.,
Gresz, V.,
Kwon, T. H.,
Jensen, U. B.,
Frokiaer, J.,
and Nielsen, S.
(2001)
Am. J. Physiol.
1,
F1047-F1057
|
| 11.
|
Garcia, F.,
Kierbel, A.,
Larocca, M.,
Gradilone, S.,
Splinter, P.,
LaRusso, N.,
and Marinelli, R.
(2001)
J. Biol. Chem.
276,
12147-12152[Abstract/Free Full Text]
|
| 12.
|
Seglen, P.
(1976)
Methods Cell Biol.
13,
29-83[Medline]
[Order article via Infotrieve]
|
| 13.
|
Lazaridis, K.,
Tietz, P., Wu, T.,
Kip, S.,
Dawson, P.,
and LaRusso, N.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
11092-11097[Abstract/Free Full Text]
|
| 14.
|
Cefaratti, C.,
Romani, A.,
and Scarpa, A.
(2000)
J. Biochem. (Tokyo)
275,
3772-3780
|
| 15.
|
Marinelli, R.,
Tietz, P.,
Pham, L.,
Rueckert, L.,
Agre, P.,
and LaRusso, N.
(1999)
Am. J. Physiol.
39,
G280-G286
|
| 16.
|
Scharschmidt, B. F.,
Keefe, E. B.,
Blankenship, N. M.,
and Ockner, R. K.
(1979)
J. Lab. Clin. Med.
93,
790-799[Medline]
[Order article via Infotrieve]
|
| 17.
|
Tuma, P.,
Finnegan, C., Yi, J.,
and Hubbard, A.
(1999)
J. Cell Biol.
145,
1089-1102[Abstract/Free Full Text]
|
| 18.
|
Gerloff, T.,
Geier, A.,
Stieger, B.,
Hagenbuch, B.,
Meier, P.,
Matern, S.,
and Gartung, C.
(1999)
Gastroenterology
117,
1408-1415[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
van Hoek, A. N.,
de Jong, M. D.,
and van Os, C. H.
(1990)
Biochem. Biophys. Acta
1030,
203-210[Medline]
[Order article via Infotrieve]
|
| 20.
|
Cova, E.,
Gong, A.,
Marinelli, R. A.,
and LaRusso, N. F.
(2001)
Hepatology
34,
456-463[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Ford, P.,
Merot, J.,
Jawerbaum, A.,
Gimeno, M. A. F.,
Caputto, C.,
and Parisi, M.
(2000)
J. Membr. Biol.
176,
151-158[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Echevarria, M.,
Windhager, E. E.,
and Frindt, G.
(1996)
J. Biol. Chem.
271,
25079-25082[Abstract/Free Full Text]
|
| 23.
|
Graf, J.,
and Boyer, J. L.
(1990)
J. Hepatol.
10,
387-394[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Ishikawa, Y.,
Showronski, M. T.,
Inoue, N.,
and Ishida, H.
(1999)
Biochem. Biophys. Res. Commun.
265,
94-100[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Marinelli, R. A.,
Pham, L.,
Agre, P.,
and LaRusso, N. F.
(1997)
J. Biol. Chem.
272,
12984-12988[Abstract/Free Full Text]
|
| 26.
|
Marinelli, R.,
Pham, L.,
Tietz, P.,
and LaRusso, N.
(2000)
Hepatology
31,
1313-1317[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Hayakawa, T.,
Bruck, R., Ng, O.,
and Boyer, J.
(1990)
Am. J. Physiol.
259,
G727-G735[Medline]
[Order article via Infotrieve]
|
| 28.
|
Boyer, J. L.,
and Soroka, C. J.
(1995)
Gastroenterology
109,
1600-1611[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Benedetti, A.,
Strazzabosco, M., Ng, O.,
and Boyer, J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
792-796[Abstract/Free Full Text]
|
| 30.
|
Roelofsen, H.,
Soroka, C.,
Keppler, D.,
and Boyer, J.
(1998)
J. Cell Sci.
111,
1137-1145[Abstract]
|
| 31.
|
Soroka, C.,
Pate, M.,
and Boyer, J.
(1999)
J. Biol. Chem.
274,
26416-26424[Abstract/Free Full Text]
|
| 32.
|
Fotiadis, D.,
Hasler, L.,
Muller, D.,
Stahlberg, H.,
Kistler, J.,
and Engel, A.
(2000)
J. Mol. Biol.
300,
779-789[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Hurley, P.,
Ferguson, C.,
Kwon, T.,
Anderson, M.,
Norman, A.,
Steward, M.,
Nielsen, S.,
and Case, R.
(2001)
Am. J. Physiol.
280,
G701-G709
|
| 34.
|
Ishibashi, K.,
Kuwahara, M.,
Kageyama, Y.,
Tohsaka, A.,
Marumo, F.,
and Sasaki, S.
(1997)
Biochem. Biophys. Res. Commun.
237,
714-718[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Koyama, Y.,
Yamanoto, T.,
Kondo, D.,
Funaki, H.,
Yaoita, E.,
Kawasaki, K.,
Sato, N.,
Hatakeyama, K.,
and Kihara, I.
(1997)
J. Biol. Chem.
272,
30329-30333[Abstract/Free Full Text]
|
| 36.
|
Tani, T.,
Koyama, Y.,
Nihei, K.,
Hatakeyama, S.,
Ohshiro, K.,
Yoshida, Y.,
Yaoita, E.,
Sakai, Y.,
Hatakeyama, K.,
and Tamamoto, T.
(2001)
Arch. Histol. Cytol.
64,
159-168[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Boyer, J.
(1993)
in
Hepatic Transport and Bile Secretion
(Tavoloni, N.
, and Berk, P. D., eds)
, pp. 597-606, Raven Press, New York
|
| 38.
|
Boyer, J.,
Elias, E.,
and Layden, T.
(1979)
Yale J. Biol. Med.
52,
61-67[Medline]
[Order article via Infotrieve]
|
| 39.
|
Graf, J.,
Gautam, A.,
and Boyer, J.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
6516-6520[Abstract/Free Full Text]
|
| 40.
|
Roberts, S.,
Yano, M.,
Ueno, Y.,
Pham, L.,
Alpini, G.,
Agre, P.,
and LaRusso, N.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
13009-13013[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Calamita, D. Ferri, P. Gena, F. I. Carreras, G. E. Liquori, P. Portincasa, R. A. Marinelli, and M. Svelto
Altered expression and distribution of aquaporin-9 in the liver of rat with obstructive extrahepatic cholestasis
Am J Physiol Gastrointest Liver Physiol,
October 1, 2008;
295(4):
G682 - G690.
[Abstract]
[Full Text]
[PDF]
|